Breaking News Instant updates and real-time market news.

ABT

Abbott

$89.60 /

-0.82 (-0.91%)

, ABMD

Abiomed

$181.64 /

-1.25 (-0.68%)

04:55
01/28/20
01/28
04:55
01/28/20
04:55

The Society of Thoracic Surgeons to hold annual meeting

56th Annual Meeting of STS will be held in New Orleans on January 25-28.

ABT

Abbott

$89.60 /

-0.82 (-0.91%)

ABMD

Abiomed

$181.64 /

-1.25 (-0.68%)

ANGO

AngioDynamics

$14.18 /

-0.29 (-2.00%)

ATRC

AtriCure

$37.98 /

+0.44 (+1.17%)

BDX

Becton Dickinson

$279.79 /

+1.57 (+0.56%)

BSX

Boston Scientific

$42.66 /

-0.54 (-1.25%)

CRY

CryoLife

$30.02 /

+0.015 (+0.05%)

EW

Edwards Lifesciences

$228.97 /

-1.47 (-0.64%)

ISRG

Intuitive Surgical

$567.76 /

-21.25 (-3.61%)

IQV

Iqvia

$157.15 /

-0.985 (-0.62%)

JNJ

Johnson & Johnson

$148.65 /

+0.33 (+0.22%)

LMAT

LeMaitre

$36.93 /

+0.33 (+0.90%)

MDT

Medtronic

$119.26 /

+0.025 (+0.02%)

MMSI

Merit Medical

$36.05 /

-0.55 (-1.50%)

OCX

OncoCyte

$2.70 /

-0.1 (-3.57%)

WTKWY

Wolters Kluwer

$0.00 /

+ (+0.00%)

ZBH

Zimmer Biomet

$148.04 /

+0.335 (+0.23%)

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 04

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 10

    Feb

  • 10

    Feb

  • 11

    Feb

  • 18

    Feb

  • 09

    Mar

  • 13

    Mar

  • 17

    Mar

  • 26

    Mar

  • 14

    Apr

ABT Abbott
$89.60 /

-0.82 (-0.91%)

01/23/20 Wells Fargo
Abbott price target raised to $103 from $97 at Wells Fargo
01/23/20 Stifel
Abbott price target raised to $104 from $95 at Stifel
01/10/20 Wells Fargo
Wells says PTAB ruling of 'zero importance' to bigger Abbott-Edwards fight
01/02/20 Guggenheim
Guggenheim upgrades Medtronic, downgrades Abbott on 'converging fundamentals'
ABMD Abiomed
$181.64 /

-1.25 (-0.68%)

01/13/20 William Blair
Abiomed's return to sustained growth potentially delayed, says William Blair
01/13/20 Piper Sandler
Abiomed sales, guidance 'disappointing,' says Piper Sandler
11/19/19 William Blair
New data 'another hurdle' Abiomed needs to overcome, says William Blair
11/19/19 Jefferies
Abiomed 'dust storm around Impella' should settle over time, says Jefferies
ANGO AngioDynamics
$14.18 /

-0.29 (-2.00%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
04/01/19 KeyBanc
AngioDynamics upgraded to Overweight from Sector Weight at KeyBanc
ATRC AtriCure
$37.98 /

+0.44 (+1.17%)

01/27/20 Piper Sandler
AtriCure study enrollment a positive indication, says Piper Sandler
01/21/20 BTIG
AtriCure price target raised to $42 from $35 at BTIG
01/13/20 Piper Sandler
AtriCure 2020 outlook likely to be conservative, says Piper Sandler
01/07/20 Piper Sandler
Piper Sandler remains bullish on AtriCure as aMAZE enrollment completes
BDX Becton Dickinson
$279.79 /

+1.57 (+0.56%)

01/08/20 Barclays
Becton Dickinson downgraded to Equal Weight from Overweight at Barclays
11/13/19 KeyBanc
Becton Dickinson price target lowered to $256 from $262 at KeyBanc
11/05/19 Piper Sandler
Becton Dickinson FY20 guidance seems conservative, says Piper Jaffray
11/01/19 Cowen
Becton Dickinson Q4 could prove to be challenging, says Cowen
BSX Boston Scientific
$42.66 /

-0.54 (-1.25%)

01/17/20 Piper Sandler
FDA recommendation a 'solid tailwind' for Boston Scientific, says Piper Sandler
01/15/20 Cowen
Boston Scientific weakness a buying opportunity, says Cowen
01/14/20 Piper Sandler
Boston Scientific's new products should accelerate growth, says Piper Sandler
12/30/19 Cowen
Boston Scientific price target raised to $52 from $47 at Cowen
CRY CryoLife
$30.02 /

+0.015 (+0.05%)

12/11/19
Fly Intel: Top five analyst upgrades
12/11/19 Needham
CryoLife upgraded to Buy from Hold at Needham
10/21/19 Oppenheimer
CryoLife initiated with an Outperform at Oppenheimer
10/21/19 Oppenheimer
CryoLife initiated with an Outperform at Oppenheimer
EW Edwards Lifesciences
$228.97 /

-1.47 (-0.64%)

01/10/20
Fly Intel: Top five analyst upgrades
01/09/20 Oppenheimer
Edwards Lifesciences upgraded to Outperform from Perform at Oppenheimer
01/08/20 Credit Suisse
Edwards Lifesciences remains a High Conviction Top Pick at Credit Suisse
ISRG Intuitive Surgical
$567.76 /

-21.25 (-3.61%)

01/27/20 Deutsche Bank
Deutsche Bank downgrades Intuitive Surgical on 'overlooked' third party threat
01/27/20 Deutsche Bank
Intuitive Surgical downgraded to Hold from Buy at Deutsche Bank
01/24/20 JPMorgan
Intuitive Surgical price target raised to $665 from $575 at JPMorgan
01/24/20 Cantor Fitzgerald
Intuitive Surgical procedure guidance conservative, says Cantor Fitzgerald
IQV Iqvia
$157.15 /

-0.985 (-0.62%)

01/13/20 Morgan Stanley
Veeva upgraded to Overweight following underperformance at Morgan Stanley
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Iqvia initiated with an Overweight at Wells Fargo
01/06/20 Citi
Iqvia initiated with a Buy at Citi
JNJ Johnson & Johnson
$148.65 /

+0.33 (+0.22%)

01/27/20 Credit Suisse
Johnson & Johnson price target raised to $170 from $163 at Credit Suisse
01/21/20 SVB Leerink
SVB Leerink bearish on Arrowhead, initiates with an Underperform
01/10/20 BWS Financial
Anika acquisitions set up direct competition with partner, says BWS Financial
01/09/20 JMP Securities
Argenx price target raised to $170 from $164 at JMP Securities
LMAT LeMaitre
$36.93 /

+0.33 (+0.90%)

10/24/19 Lake Street
Lake Street upgrades LeMaitre to Buy, boosts target to $40 from $34
10/24/19 Lake Street
LeMaitre upgraded to Buy from Hold at Lake Street
10/24/19 First Analysis
LeMaitre downgraded to Outperform from Strong Buy at First Analysis
10/14/19 First Analysis
LeMaitre upgraded to Strong Buy from Outperform at First Analysis
MDT Medtronic
$119.26 /

+0.025 (+0.02%)

01/21/20 Piper Sandler
Medtronic price target raised to $135 from $125 at Piper Sandler
01/13/20 Piper Sandler
Axonics selloff on Medtronic approval not warranted, says Piper Sandler
01/07/20 SunTrust
Medtronic initiated with a Buy at SunTrust
MMSI Merit Medical
$36.05 /

-0.55 (-1.50%)

01/14/20 Piper Sandler
Merit Medical price target raised to $42 from $30 at Piper Sandler
12/12/19 Wells Fargo
Merit Medical downgraded to Underweight from Equal Weight at Wells Fargo
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
12/12/19 Wells Fargo
Merit Medical downgraded to Underweight from Equal Weight at Wells Fargo
OCX OncoCyte
$2.70 /

-0.1 (-3.57%)

09/05/19 Piper Sandler
OncoCyte acquisition of Razor Genomics stake 'smart,' says Piper Jaffray
08/15/19 Piper Sandler
OncoCyte delayed DetermaVu study by 6-9 months, says Piper Jaffray
07/03/19 Benchmark
BioTime sale of OncoCyte shares expands shareholder base, says Benchmark
06/27/19 Benchmark
OncoCyte reaction to DetermaVu delay overdone, says Benchmark
WTKWY Wolters Kluwer
$0.00 /

+ (+0.00%)

01/20/20 Goldman Sachs
Wolters Kluwer downgraded to Sell from Neutral at Goldman Sachs
05/17/19 JPMorgan
Wolters Kluwer downgraded to Underweight from Neutral at JPMorgan
ZBH Zimmer Biomet
$148.04 /

+0.335 (+0.23%)

01/10/20 Cantor Fitzgerald
Cantor still bullish on Medical Devices & Suppliers heading into 2020
01/07/20 SunTrust
Zimmer Biomet initiated with a Buy at SunTrust
01/07/20 Piper Sandler
Zimmer Biomet upgraded to Overweight from Neutral at Piper Sandler
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG

TODAY'S FREE FLY STORIES

Earnings
Berkshire Hathaway reports Q4 net earnings $4.42B vs. $5.72B last year » 14:06
02/22/20
02/22
14:06
02/22/20
14:06
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

At December 31, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
CommScope downgraded to Hold from Buy at Deutsche Bank » 14:02
02/22/20
02/22
14:02
02/22/20
14:02
COMM

CommScope

$12.62 /

+0.07 (+0.56%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Warren Buffet right to scarf up Kroger stock, Barron's says » 10:24
02/22/20
02/22
10:24
02/22/20
10:24
KR

Kroger

$30.31 /

+0.53 (+1.78%)

, WMT

Walmart

$118.58 /

+0.86 (+0.73%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

Warren Buffett's…

Warren Buffett's Berkshire Hathaway (BRK.B) recently paid $549M for a 2.3% stake in Kroger (KR) as the chain grows digital sales by 21% year over year, Jack Hough writes in this week's edition of Barron's. Kroger goes for less than 13 times projected earnings, a 45% discount to Walmart (WMT), the author notes, adding, however, that both companies are expected to increase earnings per share by 4% to 6% during the year through January 2021. And Kroger stands to benefit indirectly as traditional supermarket shoppers migrate to Walmart.com, he contends. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Virgin Galactic stock outperformance 'just hype,' Barron's says » 10:19
02/22/20
02/22
10:19
02/22/20
10:19
SPCE

Virgin Galactic

$33.70 /

-3.49 (-9.38%)

The latest frenzy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Caterpillar stock looks cheap, Barron's says » 07:32
02/22/20
02/22
07:32
02/22/20
07:32
CAT

Caterpillar

$137.25 /

+0.325 (+0.24%)

Caterpillar stock has…

Caterpillar stock has dipped to $137 from $150 at the start of this year, while the broad U.S. market has nudged a few percent higher, Jack Hough writes in this week's edition of Barron's. While the author acknowledges that fewer than half of analysts who cover the stock recommend buying it, Hough tells investors to consider doing so just the same. This year's earnings could mark a near-term trough for Caterpillar, while the stock's current valuation implies that U.S. economy is about to slip into recession, which seems unlikely, he argues. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Intelsat could be 'a casualty' in brewing 5G showdown, Barron's says » 07:29
02/22/20
02/22
07:29
02/22/20
07:29
I

Intelsat

$4.50 /

-0.03 (-0.66%)

Intelsat's stock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 07:19
02/22/20
02/22
07:19
02/22/20
07:19
GE

General Electric

$12.24 /

-0.285 (-2.28%)

, HON

Honeywell

$179.90 /

-0.78 (-0.43%)

, AMAT

Applied Materials

$64.27 /

-2.15 (-3.24%)

, LRCX

Lam Research

$316.74 /

-11.65 (-3.55%)

, MU

Micron

$56.98 /

-2.03 (-3.44%)

, WDC

Western Digital

$67.00 /

-2.04 (-2.95%)

, LITE

Lumentum

$83.21 /

-3.13 (-3.63%)

, ACIA

Acacia Communications

$68.69 /

-0.07 (-0.10%)

, NPTN

NeoPhotonics

$7.20 /

-0.31 (-4.13%)

, IIVI

II-VI

$34.73 /

-2.39 (-6.44%)

, ANTM

Anthem

$294.81 /

+0.48 (+0.16%)

, CNC

Centene

$65.41 /

-0.33 (-0.50%)

, CVS

CVS Health

$71.53 /

-0.42 (-0.58%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, MOH

Molina Healthcare

$149.82 /

-0.72 (-0.48%)

, UNH

UnitedHealth

$301.26 /

-0.705 (-0.23%)

, CUDA

Barracuda

$0.00 /

+ (+0.00%)

, CHKP

Check Point

$116.32 /

-1.21 (-1.03%)

, FFIV

F5 Networks

$133.38 /

+0.49 (+0.37%)

, FEYE

FireEye

$15.49 /

-0.19 (-1.21%)

, FTNT

Fortinet

$114.41 /

-3.62 (-3.07%)

, IMPV

Imperva

$0.00 /

+ (+0.00%)

, PANW

Palo Alto Networks

$242.86 /

-6.24 (-2.51%)

, PFPT

Proofpoint

$123.84 /

-1.97 (-1.57%)

, QLYS

Qualys

$91.49 /

-2.8 (-2.97%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/22/20
02/22
04:55
02/22/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eBay says Payments expected to generate $2B of revenue by 2022 » 18:42
02/21/20
02/21
18:42
02/21/20
18:42
EBAY

eBay

$38.19 /

+0.51 (+1.35%)

In addition to…

In addition to eBay's portfolio review, the company's management team has executed numerous value creating actions since the beginning of 2019 that are transforming eBay's business and strengthening its foundation for growth. Among others, these actions include: Scaled Managed Payments in the U.S. and Germany; by 2022, Payments is expected to generate $2B of revenue and $0.5B of operating income; Delivered a point of margin improvement and committed to at least 2 additional points of margin expansion by 2022 while investing in revenue growth initiatives; Executed $5B in share buybacks and recently announced expansion of 2020 share buyback plan from $1.5B to $4.5B; Implemented eBay's first ever dividend and committed to a 14% increase in 2020; Increased focus on Marketplace volume growth with a reorganization of the executive leadership team and a re-prioritized customer-focused plan that includes improved vertical buyer experiences, more data & tools for sellers, and increased platform conversion leveraging an expanded structured data foundation. eBay's Board and management team are confident that the above actions will help achieve the previously stated priorities for 2020 and position eBay for sustainable, profitable long-term growth.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eBay says in 'active discussions with multiple parties' for sale of Classifieds » 18:39
02/21/20
02/21
18:39
02/21/20
18:39
EBAY

eBay

$38.19 /

+0.51 (+1.35%)

eBay issued the following…

eBay issued the following statement regarding the previously announced strategic review of eBay's Classifieds Group: "eBay has been exploring potential value-creating alternatives for Classifieds and continues to be in active discussions with multiple parties regarding a potential transaction. As previously noted, eBay expects to provide an update regarding this process by the middle of the year. eBay remains committed to maximizing the value of Classifieds for eBay shareholders. eBay's Board and management are committed to driving significant returns to shareholders by maximizing the value of Classifieds and positioning our Marketplace business for long-term success," said Scott Schenkel, interim CEO of eBay. "The Classifieds review process, together with the StubHub sale and our initiatives to increase volume, revenues, margins, and cash flow while continuing to invest in long-term profitable growth, demonstrate this commitment. We are acting with urgency while focusing on the ultimate objective of maximizing the value of Classifieds."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Italy reports first coronavirus-related death, Bloomberg says » 17:47
02/21/20
02/21
17:47
02/21/20
17:47
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$333.48 /

-3.49 (-1.04%)

Bloombereg cites…

Bloombereg cites Corriere.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Citi sees 'reasonably possible' legal costs of up to $1.3B in aggregate » 17:46
02/21/20
02/21
17:46
02/21/20
17:46
C

Citi

$76.45 /

-1.76 (-2.25%)

According to a regulatory…

According to a regulatory filing, Citi estimated that the reasonably possible unaccrued loss for various legal matters ranges up to roughly $1.3B in the aggregate. For some of the matters included within this estimation, an accrual has been made because a loss is believed to be both probable and reasonably estimable, but an exposure to loss exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, although estimable, is believed to be reasonably possible, but not probable; in these cases, the estimate reflects the reasonably possible loss or range of loss. As of December 31, 2019, Citigroup estimates that the reasonably possible unaccrued loss for these matters ranges up to approximately $1.3B in the aggregate. These estimates are based on currently available information. As available information changes, the matters for which Citigroup is able to estimate will change, and the estimates themselves will change. In addition, while many estimates presented in financial statements and other financial disclosures involve significant judgment and may be subject to significant uncertainty, estimates of the range of reasonably possible loss arising from litigation and regulatory proceedings are subject to particular uncertainties.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
WarnerMedia's HBO Max to include reunion special of 'Friends,' WSJ reports » 17:41
02/21/20
02/21
17:41
02/21/20
17:41
T

AT&T

$38.54 /

-0.075 (-0.19%)

WarnerMedia's HBO…

WarnerMedia's HBO Max service will include a special reunion of the television series "Friends" as well as all of the show's previous episodes when the streaming service rolls out in May, the Wall Street Journal's Allison Prang and Joe Flint report. The company said that all six of the main stars of "Friends" will be part of the reunion special, the authors say. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FleetCor's Johnson sells 15,000 common shares » 17:35
02/21/20
02/21
17:35
02/21/20
17:35
FLT

FleetCor

$308.94 /

-8.45 (-2.66%)

In a regulatory filing,…

In a regulatory filing, FleetCor Technologies director Mark A. Johnson disclosed the sale of 15,000 common shares of the company at a price of $321.333 per share on February 19.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon wants internal DOD documents in JEDI cloud case, Bloomberg reports » 17:31
02/21/20
02/21
17:31
02/21/20
17:31
AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

, MSFT

Microsoft

$178.46 /

-5.9 (-3.20%)

Amazon (AMZN) has asked a…

Amazon (AMZN) has asked a court to force the U.S. government to provide documents related to Defense Secretary Mark Esper's decision to recuse himself from making decisions on the $10B JEDI cloud contract that the Pentagon awarded to Microsoft (MSFT) in December, Bloomberg's Naomi Nix reports. According to a court filing, Amazon is eyeing a trove of documents to strengthen its challenge of the Pentagon's JEDI cloud contract, Nix says. Amazon has claimed that U.S. President Donald Trump's meddling in the matter cost the ecommerce giant the contract, Nix notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Idexx Laboratories director sells 39.1K shares of common stock » 17:29
02/21/20
02/21
17:29
02/21/20
17:29
IDXX

Idexx Laboratories

$278.55 /

-2.92 (-1.04%)

In a regulatory filing,…

In a regulatory filing, Idexx Laboratories disclosed that its director Jonathan Ayers sold 39.1K shares of common stock on February 19th. The total transaction size was about $11.5M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Jernigan Capital cuts quarterly dividend to 23c from 35c per share » 17:24
02/21/20
02/21
17:24
02/21/20
17:24
JCAP

Jernigan Capital

$20.30 /

+0.07 (+0.35%)

The dividend is payable…

The dividend is payable on April 15, 2020 to stockholders of record on April 1, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Synthesis Energy Systems discloses additional Nasdaq delinquency notice » 17:23
02/21/20
02/21
17:23
02/21/20
17:23
SES

Synthesis Energy Systems

$5.49 /

+ (+0.00%)

Synthesis Energy Systems…

Synthesis Energy Systems announced that the company received an additional staff determination delinquency notification letter from the The Nasdaq Stock Market LLC due to the company's non-compliance with Nasdaq Listing Rule 5250(c)(1), as a result of the company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2019. The company is required to present its views with respect to this additional deficiency to the Panel in writing no later than February 27, 2020 under Listing Rule 5810(d). Robert Rigdon, the company's CEO, commented: "The company is progressing its important merger transaction with AFE and acquisition of additional ownership in Batchfire Resources. We believe these transactions, now underway, have the potential to bring growth and value to the company's shareholders and debenture holders. The late filing of our Form 10-Q for the quarter ended December 31, 2019 is the result delays related to derivative accounting protocol and value analysis regarding the merger-related debt restructuring undertaken by the company in October 2019. We are actively working with our auditors and our advisors to complete the work in the most expeditious manner possible."

Syndicate
Pebblebrook Hotel files automatic mixed securities shelf  17:23
02/21/20
02/21
17:23
02/21/20
17:23
PEB

Pebblebrook Hotel

$24.90 /

+0.3 (+1.22%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Phillips 66 awarded $795.34M Defense Logistics Agency contract » 17:20
02/21/20
02/21
17:20
02/21/20
17:20
PSX

Phillips 66

$89.22 /

-1.015 (-1.12%)

Phillips 66 has been…

Phillips 66 has been awarded a $795.34M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract under solicitation for various types of fuel. These were competitive acquisitions with 32 offers received. These are one-year contracts with a 30-day carryover. Work has an April 30, 2021, performance completion date. Using customer is Defense Logistics Agency Energy. Type of appropriation is FY20 defense working capital funds. The contracting activity is the Defense Logistics Agency Energy.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lockheed Martin awarded $233.04M Navy contract action » 17:16
02/21/20
02/21
17:16
02/21/20
17:16
LMT

Lockheed Martin

$427.29 /

+1.345 (+0.32%)

Lockheed Martin was…

Lockheed Martin was awarded a $233.04M firm-fixed-price undefinitized contract action for the procurement of Mk 41 Vertical Launching System vertical launcher module assemblies, modernization kits and spare components. This contract combines purchases for the Navy and the governments of Korea, Finland and Germany under the Foreign Military Sales program. Work is expected to be completed by March 2025. FY18, FY19 and FY20 shipbuilding and conversion, and foreign military sales funding in the amount of $46.61M was obligated at time of award and will not expire at the end of the current fiscal year. This contract was competitively procured via the Federal Business Opportunities website, with one offer received. The Naval Sea Systems Command is the contracting activity.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xilinx recommends rejection of TRC Capital's "mini-tender" offer » 17:04
02/21/20
02/21
17:04
02/21/20
17:04
XLNX

Xilinx

$87.74 /

-2.09 (-2.33%)

Xilinx announced that it…

Xilinx announced that it has been notified of an unsolicited "mini-tender" offer by TRC Capital to purchase up to 1.5M shares of its common stock (approximately 0.6% of outstanding shares) at $81.75 per share. The offer price is approximately 4.52% below the $85.62 per share price that Xilinx common stock closed at on February 7, 2020 - the last trading day prior to the date when TRC Capital commenced its mini-tender offer - and is approximately 8.95% below the $89.79 per share at which Xilinx common stock closed on February 20, the day prior to this release. Xilinx does not endorse TRC Capital's unsolicited offer and recommends that Xilinx stockholders reject the offer and not tender their shares in response to it. Not only is the mini-tender offer at a price below the market price for Xilinx shares, as of today's date, it is also subject to numerous conditions, including TRC Capital's ability to obtain financing. Xilinx is not associated in any way with TRC Capital, its mini-tender offer or the offer documentation, nor did Xilinx have advance notice of this mini-tender offer.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Trip.com reschedules Q4 results announcement due to coronavirus » 17:03
02/21/20
02/21
17:03
02/21/20
17:03
TCOM

Trip.com Group

$33.06 /

-0.8 (-2.36%)

Trip.com Group Limited…

Trip.com Group Limited announced that it has rescheduled the announcement date for its financial results for the fourth quarter and full year 2019 to after the U.S. market closes on March 18, 2020. Trip.com Group rescheduled the announcement date of its fourth quarter and full year 2019 financial results due to the evolving situation brought on by the novel coronavirus outbreak in China. The revised date would give the company more time to observe business condition and provide visibility for the first quarter of 2020. Trip.com Group's management will hold an earnings conference call at 8:00 PM on March 18, 2020, U.S. Eastern Time.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
InVivo Therapeutics files to sell common stock, warrants, no amount given » 17:02
02/21/20
02/21
17:02
02/21/20
17:02
NVIV

InVivo Therapeutics

$6.92 /

-0.1 (-1.42%)

H.C. Wainwright & Co.…

H.C. Wainwright & Co. is acting as exclusive placement agent in connection with this offering.

Periodicals
Google settles with state AGs over consultants in antitrust inquiry, CNBC says » 17:01
02/21/20
02/21
17:01
02/21/20
17:01
GOOG

Alphabet

$1,484.27 /

-33.78 (-2.23%)

, GOOGL

Alphabet Class A

$1,482.84 /

-33.7 (-2.22%)

Google has reached a…

Google has reached a settlement agreement with state attorneys general over outside consultants hired to work on the states' antitrust probe, CNBC's Ylan Mui and Lauren Feiner report. The settlement, which would allow consultants to continue advising the states' probe but also impose certain confidentiality restrictions, means that possible roadblocks to the investigation may be cleared for the time being, allowing the attorneys general to continue looking into the search giant's business, the authors say. A delay to the probe could hinder the states' ability to uncover important data about Google's competitive practices, the authors note. Texas is leading the investigation into the company's digital advertising operations, which is backed by 49 other attorneys general from U.S. states and territories, the authors note. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.